INTRODUCTION: The objective of this study was to estimate the cost-effectiveness of adding
human papillomavirus (HPV) vaccination of 12-year-old males to a female-only vaccination …

We assessed the public health impact and value of vaccinating boys and men with the
quadrivalent HPV vaccine in the United States. We used mathematical population models …

Estimates of the direct medical costs attributable to human papillomavirus (HPV) can help to
quantify the economic burden of HPV and to illustrate the potential benefits of HPV …

We describe a simplified model, based on the current economic and health effects of human
papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old …

Background A nonavalent human papillomavirus (HPV) vaccine has been licensed for use
in women and men up to age 45 years in the United States. The cost-effectiveness of HPV …

Human papillomaviruses are DNA viruses that infect skin or mucosal cells. In the genital
tract HPV (especially types 6 and 11) cause genital warts, the commonest viral sexually …

Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor
for cervical cancer. Given the substantial disease and death associated with HPV and …

Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause
of several cancers, including cervical cancer, and genital warts. Although cervical cancer …

BY ANY MEASURE, GENITAL HUMAN PAPILLOMAVIRUS (HPV) infection and HPV-
associated cervical can-cer are significant national and global public health concerns. An …

Background The cost-effectiveness of prophylactic vaccination against human
papillomavirus types 16 (HPV-16) and 18 (HPV-18) is an important consideration for …